US5322790A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Islet isolation process
Assignee: McDonnell Douglas Corp
•
Filing: 1989-06-09
•
Granted: 1994-06-21
•
Expires: 2009-06-09
Abstract
Abstract A method of producing intact islets of Langerhans in an insulin producing condition uses a mixture of Hank's solution and 10% by volume fetal calf serum to ductally distend the human pancreas. The exocrine tissue of the pancreas is digested at about 37 DEG C. by an enzyme preparation of collagenase, trypsin and proteolytic enzyme present in the mixture at a level of about 0.2% by weight. The digestion is monitored at regular intervals during the process. The digested pancreas is comminuted, filtered and intact islets of Langerhans are recovered. The recovered islets retain their insulin producing properties.
Inventors
- 👤 David W. Scharp
- 👤 Paul E. Lacy
- 👤 Edward H. Finke
- 👤 Thomas J. Poteat
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 03:59
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/37; A61K35/39
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
79 words
The method of recovering an in vitro islet collection containing isolated islets of Langerhans from a pancreas, said method comprising distending the pancreas with an enzyme preparation comprising collagenase, disrupting at least a portion of the previously distended pancreas by mechanical disruption to break down the exocrine tissue of the pancreas and free islets, substantially isolating the freed islets from the exocrine tissue of the pancreas, and recovering at least about 66,600 isolated morphologically and functionally intact viable islets.
Claim 2
Independent Claim
79 words
The method of recovering an in vitro islet collection containing isolated islets of Langerhans from a pancreas, said method comprising distending the pancreas with an enzyme preparation comprising collagenase, disrupting at least a portion of the previously distended pancreas by mechanical disruption to break down the exocrine tissue of the pancreas and free islets, substantially isolating the freed islets from the exocrine tissue of the pancreas, and recovering at least about 66,600 isolated morphologically and functionally intact viable islets.
Claim 3
Dependent Claim
32 words
The method of claim 1 in which said islets secrete insulin at a basal rate of at least about 0.9μ units/islet/minute and at a stimulated rate of at least about 2.2μ units/islet/minute.
Claim 4
Dependent Claim
14 words
The method of claim 1 in which said pancreas is derived from pig pancreas.
Claim 5
Dependent Claim
14 words
The method of claim 1 in which said pancreas is derived from human pancreas.
Claim 6
Dependent Claim
16 words
The method of claim 1 in which said pancreas is derived from a large animal pancreas.
Claim 7
Dependent Claim
23 words
The method of claim 1 in which the islets in said recovered islet collection contain no more than about 5% pancreatic tissue impurities.
References Cited (Backward Citations)
US4868121A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-06-20 | 1997-12-20 | 1998-06-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-06-20 | 2001-12-20 | 2002-06-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-06-20 | 2005-12-20 | 2006-06-21 | $7700.00 | Window Closed / Lapsed |